Skip to content

Investigating Attention Control Training in psychosis

A study to investigate the role of attention in psychotic symptoms and the feasibility and acceptability of using attention training as a strategy for individuals with psychosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN06815355
Enrollment
40
Registered
2014-04-14
Start date
2014-05-16
Completion date
Unknown
Last updated
2017-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia, schizoaffective disorder or delusional disorder Mental and Behavioural Disorders Schizophrenia

Interventions

Patients are randomised to two groups: 1. Intervention: The intervention group will receive Attention Training (n=20). ATT will be delivered over eight sessions. During these sessions, participants wi

Sponsors

Greater Manchester West NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. In contact with mental health services 2. Either meets ICD-10 criteria for schizophrenia, schizoaffective disorder or delusional disorder, or meet entry criteria for early intervention In psychosis services (operationally defined using the PANSS) 3. Score at least four on PANSS delusions or hallucinations items 4. Help seeking 5. Competent and willing to provide written informed consent

Exclusion criteria

Exclusion criteria: 1. Moderate to severe learning disability 2. Organic impairment 3. Non-English speaking (this would prevent the use of standardised assessment instruments) 4. Inpatient/acute psychiatric care needed 5. Does not have a care coordinator or responsible clinician 6. Substance dependency 7. Deaf or hard of hearing (this would prevent use of the audio task as part of the intervention)

Design outcomes

Primary

MeasureTime frame
Feasibility will be measured using referral rates, recruitment, attendance at sessions, adherence to between-session work, and follow-up and questionnaire response rates.

Secondary

MeasureTime frame
1. The PANSS (Positive and Negative Syndrome Scale): a structured clinical interview assessing positive and negative symptoms of psychosis occurring within the last seven days 2. The HADS (Hospital Anxiety and Depression Scale): a self-report measure of anxiety and depression 3. The MCQ-30 (Meta-cognitions Questionnaire): a 30-item self-report measure of meta-cognitive beliefs 4. The CAS (Cogntive Attentional Syndrome Scale): a short self-report measure of cognitive attentional syndrome activation in the last seven days 5. The ACS (Attention Control Scale): a 20 item measure designed to assess general capacity to control attention 6. The WHOQOL: a questionnaire assessing quality of life of the participant 7. The QPR (Process of Recovery Questionnaire): a service user designed measure of recovery 8. Finally, a self-attention rating scale will be administered after the first and second ATT session for those randomly allocated the ATT plus TAU arm. The scale will utilise a likert rating to measure current intensity of self-focus on a scale ranging from -3 (entirely externally focussed) to +3 (entirely self-focussed).

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026